Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on American Tech Today.
Press releases published on May 14, 2025
Next-Generation Wireless InSite Introduces Time-Based Mobility of RF Systems, Lunar Propagation and Wideband Ray-Tracing
EIN Presswire
·
May 14, 2025
The new Wireless InSite introduces advanced capabilities including time-based mobility, lunar propagation modeling, and wideband ray-tracing with S-parameters. STATE COLLEGE, PA, UNITED STATES, May 14, 2025 /EINPresswire.com/ -- Remcom announces a new …
Desh Urs Chosen Among World's Top 50 Leaders to Follow in 2025
EIN Presswire
·
May 14, 2025
Desh Urs and iBridge: Pioneering Practical Digital Transformation for the Data-Driven World PORTLAND, OR, UNITED STATES, May 14, 2025 /EINPresswire.com/ -- In a significant recognition of transformative leadership in the digital age, Desh Urs, the …
Lithium Argentina Reports First Quarter 2025 Results
GlobeNewswire
·
May 14, 2025
ZUG, Switzerland, May 14, 2025 (GLOBE NEWSWIRE) -- Lithium Argentina AG (“Lithium Argentina” or the “Company”) (TSX: LAR) (NYSE: LAR) today announced its first quarter 2025 results. Unless otherwise stated, results are presented in United States dollar. …
Updated: Myriad Genetics to Participate in Two Upcoming Investor Healthcare Conferences
GlobeNewswire
·
May 14, 2025
SALT LAKE CITY, May 14, 2025 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, today announced that management plans to participate in the following investor healthcare conferences: …
WEB3ADS Introduces a New Approach to Advertising with WEB3 and Self-Media
EIN Presswire
·
May 14, 2025
NEW YORK, NY, UNITED STATES, May 14, 2025 /EINPresswire.com/ -- A 2024 eMarketer report underscored a growing challenge in digital advertising: click-through rates for traditional ads dropped to a historic low of 0.46%. Consumers, frustrated by …
Radical Truths Summit to Address Global Trends in Surveillance, Psychological Manipulation, and Public Autonomy
EIN Presswire
·
May 14, 2025
Virtual event to feature international experts, researchers, and targeted survivors May 21 – June 3, 2025 NA, TX, UNITED STATES, May 14, 2025 /EINPresswire.com/ -- From concerns over digital privacy to the rise in reported psychological coercion and …
Jasper Therapeutics to Present at Upcoming Investor Conferences
GlobeNewswire
·
May 14, 2025
REDWOOD CITY, Calif., May 14, 2025 (GLOBE NEWSWIRE) -- Jasper Therapeutics, Inc. (Nasdaq: JSPR) (Jasper), a clinical stage biotechnology company focused on development of briquilimab, a novel antibody therapy targeting KIT to address mast cell driven …
Calidi Biotherapeutics Reports First Quarter 2025 Financial Results and Recent Operational Highlights
GlobeNewswire
·
May 14, 2025
Bolstered management team with hires of Chief Executive Officer and Chief Medical Officer with deep biopharmaceutical experience Announced selection of IL15-superagonist as first payload to be delivered into tumors with Calidi’s first lead candidate using …
AlphaNeural Launches Beta of AI Infrastructure Platform Bridging Compute, Monetization, and Enterprise Integration
EIN Presswire
·
May 14, 2025
STEINHAUSEN, ZUG, SWITZERLAND, May 14, 2025 /EINPresswire.com/ -- AlphaNeural, a next-generation AI infrastructure provider, today announced the beta launch of its protocol-native platform, a unified ecosystem for AI Models, Agents, and Datasets. Built …
Oruka Therapeutics Reports First Quarter 2025 Financial Results and Provides Corporate Update
GlobeNewswire
·
May 14, 2025
Continued operational excellence leading to acceleration of multiple timelines: ORKA-001, targeting IL-23p19, Phase 1 trial dosing complete, with data expected in 3Q 2025 ORKA-001 Phase 2a initiation expected in 2H 2025, with efficacy readout expected in …
HP Inc. Declares Dividend
GlobeNewswire
·
May 14, 2025
PALO ALTO, Calif., May 14, 2025 (GLOBE NEWSWIRE) -- HP Inc. (NYSE: HPQ) has declared a cash dividend of $0.2894 per share on the company’s common stock. The dividend, the third in HP’s fiscal year 2025, is payable on July 2, 2025, to stockholders of record …
X4 Pharmaceuticals Announces Upcoming Presentation of Phase 2 Chronic Neutropenia Trial Data at the 30th Annual EHA Congress
GlobeNewswire
·
May 14, 2025
Meaningful and durable increases in functional neutrophils observed over 6-month trial with oral once-daily mavorixafor Majority of physicians and chronic neutropenia participants chose to significantly reduce G-CSF dosing when using mavorixafor in …
Aardvark Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Highlights
GlobeNewswire
·
May 14, 2025
Phase 3 HERO trial of ARD-101 for the treatment of hyperphagia associated with Prader-Willi Syndrome (PWS); data readout expected in early 2026 $151.3 million in cash, cash equivalents, and short-term investments supports projected operations into 2027 SAN …
Silo Pharma Selects Veloxity Labs for Bioanalytical IND-Enabling Study for our Novel Intranasal PTSD Therapy, SPC-15
GlobeNewswire
·
May 14, 2025
SARASOTA, FL, May 14, 2025 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (Nasdaq: SILO) (“Silo” or the “Company”), a developmental stage biopharmaceutical company focused on novel therapeutics and drug delivery systems, today announced that it has engaged Veloxity …
Bannix Acquisition Corp. Announces Monthly Extension to Complete its Initial Business Combination
GlobeNewswire
·
May 14, 2025
WILMINGTON, Del., May 14, 2025 (GLOBE NEWSWIRE) -- Bannix Acquisition Corp. (“Bannix”) announced today that its board of directors (the “Board”) has decided to extend the date by which Bannix must consummate an initial business combination (the “Deadline …
Aterian Reports 2025 First Quarter Financial Results
GlobeNewswire
·
May 14, 2025
SUMMIT, N.J., May 14, 2025 (GLOBE NEWSWIRE) -- Aterian, Inc. (Nasdaq: ATER) (“Aterian” or the “Company”), a consumer products company, today announced financial results for the first quarter ended March 31, 2025 (“Q1 2025”). The Company also provided an …
ImmuCell Announces Unaudited Financial Results for the Quarter Ended March 31, 2025
GlobeNewswire
·
May 14, 2025
PORTLAND, Maine, May 14, 2025 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets scientifically proven and practical products that improve the …
AEON Biopharma Reports First Quarter 2025 Financial Results and Provides Corporate Update
GlobeNewswire
·
May 14, 2025
– Continue to conduct analytical studies to prepare for a potential Biosimilar Biological Product Development (“BPD”) Type 2a meeting with the FDA in the second half of 2025 – – Pursuing a 351(k) regulatory pathway for ABP-450, which offers potential …
Jade Biosciences Reports First Quarter 2025 Financial Results and Provides Corporate Update
GlobeNewswire
·
May 14, 2025
Completed reverse merger and commenced trading on Nasdaq as JBIO Closed financing, raising approximately $300 million to date, providing cash runway through 2027 Lead candidate JADE101 expected to enter the clinic in second half of 2025, with interim …
BioCardia Reports First Quarter 2025 Business Highlights and Financial Results
GlobeNewswire
·
May 14, 2025
SUNNYVALE, Calif., May 14, 2025 (GLOBE NEWSWIRE) -- BioCardia, Inc. [Nasdaq: BCDA], a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, today reported financial results for the first quarter of …